Skip to main content
. 2025 Jul 23;18:9755–9765. doi: 10.2147/JIR.S531236

Table 3.

Comparison of UPCR Between the Two Groups During Treatment

Group Baseline 1 Month 3 Months F P Value
RASI + Finerenone 1.22 (0.64, 2.04) 0.86 (0.45, 1.83) ** 0.68 (0.34, 1.50) *** 14.895 <0.001
RASI 1.12 (0.65, 2.12) 0.91 (0.69, 1.84) 1.04 (0.57, 1.50) 1.709 0.187
U 0.002 4.092 6.336
P value 0.804 0.453 0.163
F (Time) =13.527 F (Treatment) = 0.542 F (Time * Treatment) = 3.508
P (Time) < 0.001 P (Treatment) = 0.464 P (Time * Treatment) = 0.032

Notes: Data are presented as median (IQR). ** and *** indicate significant differences compared with baseline data (P < 0.01 and P < 0.001, respectively).

Abbreviations: UPCR, Urine protein creatinine ratio; RASI, renin–angiotensin system inhibitor.